Listening to the heart-brain talk: Persistent depressive symptoms are associated with hsCRP in apparently healthy individuals at high risk for coronary artery disease

European Journal of Preventive Cardiology

Volumn 19, Issue 4, 2012, Pages 857-863

  Azar, Rima ^a   Nolan, Robert P ^b   Stewart, Donna E ^b  

^a MOUNT ALLISON UNIVERSITY   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

C reactive protein; Coronary artery disease; depressive symptoms; high risk; inflammation; interleukin 6

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; AUTACOID; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; CORONARY ARTERY DISEASE; DEPRESSION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; BLOOD; CANADA; CHI SQUARE DISTRIBUTION; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; TIME; UPREGULATION;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CANADA; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; DEPRESSION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS; UP-REGULATION;

EID: 84871697293     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/1741826711415720     Document Type: Article

References (34)

1. Mosca L. C-reactive protein - To screen or not to screen?. New Eng J Med. 2002 ; 347 (20). 1615-1617
2. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New Eng J Med. 2002 ; 347 (20). 1557-1565
3. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002 ; 105: 135-1143
4. Jeppesen J, Hansen TW, Olsen MH, Rasmussen S, Ibsen H, Torp-Pedersen C, et al. C-reactive protein, insulin resistance, and risk of cardiovascular disease: A population-based study. Eur J Cardiov Prev Rehabil. 2008 ; 15 (5). 594-598
5. Williams MJ, Millne BJ, Hancox RJ, Poulton RJ. C-reactive protein and cardiorespiratory fitness in young adults. Eur J Cardiov Prev Rehabil. 2005 ; 12 (3). 216-220
6. Steptoe A, Whitehead DL. Depression, stress, and coronary heart disease: the need for more complex models. Heart. 2006 ; 91 (4). 419-420
7. Pizzi C, Manzoli L, Mancini S, Costa GM. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. Eur Heart J. 2008 ; 29 (9). 1110-1117
8. Skala JA, Freedland KE, Carney RM. Coronary heart disease and depression: A review of recent mechanistic research. Can J Psychiatry. 2006 ; 51 (12). 738-745
9. Sternberg EM. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol. 2001 ; 169 (3). 429-435
10. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2005 ; 27 (1). 24-31
11. Van den Biggelaar AHJ, Gussekloo J, De Craen AJM, Frolich M, Stek ML, Van der Mast RC, et al. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol. 2007 ; 42 (4). 693-701
12. Kop WJ, Gottdiener JS, Tangen CM, Fried LP, McBurnie MA, Walston J, et al. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol. 2002 ; 89 (4). 419-424
13. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA. 2003 ; 100 (15). 9090-9095
14. Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, et al. Inflammatory markers in major depression and melancholia. J Affec Disord. 2001 ; 63 (1-3). 93-102
15. Lespérance F, Frasure-Smith N, Théroux P, Irwin M. The association between major depression and levels of soluble intercellular adhesion Molecule 1, Interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry. 2004 ; 161 (2). 271-277
16. Howren M, Bryant MA, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosom Med. 2009 ; 71 (2). 171-186
17. Miller GE, Freedland KE, Duntley S, Carney RM. Relation of depressive symptoms to C-reactive protein and pathogen burden (Cytomegalovirus, herpes simplex virus, Epstein-barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol. 2005 ; 95 (3). 317-321
18. Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European Men. The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation. 2005 ; 111 (18). 2299-2305
19. Steptoe A, Kunz-Ebrecht R, Owen N. Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med. 2003 ; 33 (4). 667-674
20. Ridker P, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 2007 ; 98 (8). 731-733
21. Piccinelli M, Wilkinson G. Gender differences in depression. Br J Psychiatry. 2000 ; 177: 486-492
22. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of Interleukin-6 in human disease. Ann Intern Med. 1998 ; 128 (2). 127-137
23. Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol. 2002 ; 5 (4). 401-412
24. Matthews KA, Schott LL, Bromberger J, Cyranowski J, Evenson-Rose SA, Sowers MF. Associations between depressive symptoms and inflammatory/hemostatic markers in women during the menopausal transition. Psychosom Med. 2007 ; 69: 124-130
25. Beck AT, Steer RA, Brown GK Beck Depression Inventory-II. San Antonio: The Psychological Corporation ; 1996 :
26. Schins A, Tulner D, Lousberg R, Kenis G, Delanghe J, Crijns HJ, et al. Inflammatory markers in depressed post-myocardial infarction patients. J Psychiatric Res. 2005 ; 39 (2). 137-144
27. Clyde PW, Harari AE, Getka EJ. Combined Levothyroxine plus Liothyronine compared with Levothyroxine alone in primary hypothyroidism. J Am Med Assoc. 2003 ; 290 (22). 2952-2958
28. Ridker PM. C-reactive protein: A simple test to help predict risk of heart attack and stroke. Circulation. 2003 ; 108 (12). e81 - e85
29. Yamamura M. Circulating interleukin-6 levels in adult T-cell leukaemia/lymphoma patients and correlate with adverse clinical features and survival. Br J Haematol. 1998 ; 100 (1). 129-134
30. Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, Mullington JM. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem. 2001 ; 47 (3). 426-430
31. Coudène P, Marson B, Badiou S, et al. Evaluation of the ABX Pentra 400: A newly available clinical chemistry analyser. Clin Chem Lab Med. 2005 ; 43 (7). 782-792
32. Lanza GA, Pitocco D, Navarese EP, Sestito A, Sgueglia GA, Manto A, et al. Association between cardiac autonomy dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. Eur Heart J. 2007 ; 28 (7). 814-820
33. Cohen J Statistical Power Analysis for the Behavioral Sciences. 1977. New York: Academic Press ; 1977 :
34. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary artery disease. Prospective analysis from the Women's Health Initiative Observational Study. JAMA. 2002 ; 288 (8). 980-987